|
Rank
|
PathwayID
|
Title
|
t+
|
t-
|
t+ uniq
|
com mon
|
b+ uniq
|
b+
|
b-
|
p-value
|
t-ratio
|
b-ratio
|
enrichment folds
|
| 1 | 73894 | DNA Repair | 18 | 381 | 18 | 0 | 1 | 1 | 554 | 1.42e-06 | 0.05 | 0.00 | 25.0 |
| 2 | 73890 | Double-Strand Break Repair | 8 | 391 | 8 | 0 | 0 | 0 | 555 | 8.98e-04 | 0.02 | 0.00 | bZero |
| 3 | hsa04080 | Neuroactive ligand-receptor interaction - Homo sapiens (human) | 8 | 391 | 3 | 5 | 29 | 34 | 521 | 2.08e-03 | 0.02 | 0.06 | 0.3 |
| 4 | hsa04060 | Cytokine-cytokine receptor interaction - Homo sapiens (human) | 20 | 379 | 2 | 18 | 39 | 57 | 498 | 3.61e-03 | 0.05 | 0.10 | 0.5 |
| 5 | 73951 | Homologous recombination repair of replication-independent double-strand breaks | 6 | 393 | 6 | 0 | 0 | 0 | 555 | 5.24e-03 | 0.02 | 0.00 | bZero |
| 6 | 157579 | Telomere Maintenance | 6 | 393 | 6 | 0 | 0 | 0 | 555 | 5.24e-03 | 0.02 | 0.00 | bZero |
| 7 | 73888 | Homologous Recombination Repair | 6 | 393 | 6 | 0 | 0 | 0 | 555 | 5.24e-03 | 0.02 | 0.00 | bZero |
| 8 | hsa04514 | Cell adhesion molecules (CAMs) - Homo sapiens (human) | 3 | 396 | 0 | 3 | 13 | 16 | 539 | 1.95e-02 | 0.01 | 0.03 | 0.3 |
| 9 | hsa00620 | Pyruvate metabolism - Homo sapiens (human) | 8 | 391 | 8 | 0 | 2 | 2 | 553 | 2.05e-02 | 0.02 | 0.00 | 5.6 |
| 10 | hsa04610 | Complement and coagulation cascades - Homo sapiens (human) | 1 | 398 | 0 | 1 | 9 | 10 | 545 | 3.05e-02 | 0.00 | 0.02 | 0.1 |
| 11 | hsa00480 | Glutathione metabolism - Homo sapiens (human) | 9 | 390 | 6 | 3 | 1 | 4 | 551 | 0.05 | 0.02 | 0.01 | 3.1 |
| 12 | hsa05214 | Glioma - Homo sapiens (human) | 19 | 380 | 11 | 8 | 6 | 14 | 541 | 0.07 | 0.05 | 0.03 | 1.9 |
| 13 | 76010 | Homologous DNA pairing and strand exchange | 3 | 396 | 3 | 0 | 0 | 0 | 555 | 0.07 | 0.01 | 0.00 | bZero |
| 14 | 69190 | DNA strand elongation | 3 | 396 | 3 | 0 | 0 | 0 | 555 | 0.07 | 0.01 | 0.00 | bZero |
| 15 | hsa02010 | ABC transporters - General - Homo sapiens (human) | 3 | 396 | 3 | 0 | 0 | 0 | 555 | 0.07 | 0.01 | 0.00 | bZero |
| 16 | 75154 | Recruitment of repair and signaling proteins to double-strand breaks | 3 | 396 | 3 | 0 | 0 | 0 | 555 | 0.07 | 0.01 | 0.00 | bZero |
| 17 | 69481 | G2/M Checkpoints | 3 | 396 | 3 | 0 | 0 | 0 | 555 | 0.07 | 0.01 | 0.00 | bZero |
| 18 | 76003 | Presynaptic phase of homologous DNA pairing and strand exchange | 3 | 396 | 3 | 0 | 0 | 0 | 555 | 0.07 | 0.01 | 0.00 | bZero |
| 19 | 69242 | S Phase | 6 | 393 | 5 | 1 | 1 | 2 | 553 | 0.07 | 0.02 | 0.00 | 4.2 |
| 20 | hsa03320 | PPAR signaling pathway - Homo sapiens (human) | 2 | 397 | 1 | 1 | 9 | 10 | 545 | 0.09 | 0.01 | 0.02 | 0.3 |
| 21 | hsa04115 | p53 signaling pathway - Homo sapiens (human) | 14 | 385 | 7 | 7 | 2 | 9 | 546 | 0.09 | 0.04 | 0.02 | 2.2 |
| 22 | 69239 | Synthesis of DNA | 5 | 394 | 4 | 1 | 0 | 1 | 554 | 0.09 | 0.01 | 0.00 | 7.0 |
| 23 | hsa04630 | Jak-STAT signaling pathway - Homo sapiens (human) | 14 | 385 | 4 | 10 | 23 | 33 | 522 | 0.10 | 0.04 | 0.06 | 0.6 |
| 24 | hsa05222 | Small cell lung cancer - Homo sapiens (human) | 22 | 377 | 9 | 13 | 5 | 18 | 537 | 0.10 | 0.06 | 0.03 | 1.7 |
| 25 | 187037 | TRKA signalling from the plasma membrane | 15 | 384 | 7 | 8 | 3 | 11 | 544 | 0.11 | 0.04 | 0.02 | 1.9 |
| 26 | hsa04012 | ErbB signaling pathway - Homo sapiens (human) | 20 | 379 | 9 | 11 | 5 | 16 | 539 | 0.12 | 0.05 | 0.03 | 1.7 |
| 27 | 166520 | Signalling by NGF | 20 | 379 | 9 | 11 | 5 | 16 | 539 | 0.12 | 0.05 | 0.03 | 1.7 |
| 28 | hsa00190 | Oxidative phosphorylation - Homo sapiens (human) | 10 | 389 | 8 | 2 | 4 | 6 | 549 | 0.12 | 0.03 | 0.01 | 2.3 |
| 29 | 69278 | Cell Cycle, Mitotic | 10 | 389 | 9 | 1 | 5 | 6 | 549 | 0.12 | 0.03 | 0.01 | 2.3 |
| 30 | hsa00790 | Folate biosynthesis - Homo sapiens (human) | 5 | 394 | 3 | 2 | 0 | 2 | 553 | 0.14 | 0.01 | 0.00 | 3.5 |
| 31 | hsa00650 | Butanoate metabolism - Homo sapiens (human) | 5 | 394 | 4 | 1 | 1 | 2 | 553 | 0.14 | 0.01 | 0.00 | 3.5 |
| 32 | hsa00350 | Tyrosine metabolism - Homo sapiens (human) | 8 | 391 | 6 | 2 | 2 | 4 | 551 | 0.14 | 0.02 | 0.01 | 2.8 |
| 33 | hsa00010 | Glycolysis / Gluconeogenesis - Homo sapiens (human) | 8 | 391 | 7 | 1 | 3 | 4 | 551 | 0.14 | 0.02 | 0.01 | 2.8 |
| 34 | hsa05213 | Endometrial cancer - Homo sapiens (human) | 14 | 385 | 8 | 6 | 4 | 10 | 545 | 0.14 | 0.04 | 0.02 | 1.9 |
| 35 | 114608 | Platelet degranulation | 4 | 395 | 0 | 4 | 9 | 13 | 542 | 0.14 | 0.01 | 0.02 | 0.4 |
| 36 | 114611 | Exocytosis of Alpha granule | 4 | 395 | 0 | 4 | 9 | 13 | 542 | 0.14 | 0.01 | 0.02 | 0.4 |
| 37 | hsa05220 | Chronic myeloid leukemia - Homo sapiens (human) | 17 | 382 | 8 | 9 | 5 | 14 | 541 | 0.14 | 0.04 | 0.03 | 1.7 |
| 38 | 140192 | Metabolism of xenobiotics | 11 | 388 | 7 | 4 | 4 | 8 | 547 | 0.16 | 0.03 | 0.01 | 1.9 |
| 39 | 69620 | Cell Cycle Checkpoints | 8 | 391 | 6 | 2 | 3 | 5 | 550 | 0.17 | 0.02 | 0.01 | 2.2 |
| 40 | hsa04070 | Phosphatidylinositol signaling system - Homo sapiens (human) | 8 | 391 | 4 | 4 | 1 | 5 | 550 | 0.17 | 0.02 | 0.01 | 2.2 |
| 41 | 69306 | DNA Replication | 8 | 391 | 7 | 1 | 4 | 5 | 550 | 0.17 | 0.02 | 0.01 | 2.2 |
| 42 | hsa00020 | Citrate cycle (TCA cycle) - Homo sapiens (human) | 4 | 395 | 3 | 1 | 0 | 1 | 554 | 0.17 | 0.01 | 0.00 | 5.6 |
| 43 | 69166 | Removal of the Flap Intermediate | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 44 | hsa04340 | Hedgehog signaling pathway - Homo sapiens (human) | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 45 | 110373 | Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 46 | hsa00290 | Valine, leucine and isoleucine biosynthesis - Homo sapiens (human) | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 47 | hsa00430 | Taurine and hypotaurine metabolism - Homo sapiens (human) | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 48 | hsa04740 | Olfactory transduction - Homo sapiens (human) | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 49 | 110362 | Removal of DNA patch containing abasic residue | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 50 | 140179 | Amine Oxidase reactions | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 51 | 174414 | Processive synthesis on the C-strand of the telomere | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 52 | 141333 | Monoamines are oxidized to aldehydes, producing NH3 and H2O2 | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 53 | 83572 | MRN complex relocalizes to nuclear foci | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 54 | 75177 | Assembly of the RAD50-MRE11-NBS1 complex at DNA double-strand breaks | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 55 | 75924 | Processing of DNA ends prior to end rejoining | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 56 | 69186 | Lagging Strand Synthesis | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 57 | 71384 | Ethanol catabolism | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 58 | 73889 | Nonhomologous End-joining (NHEJ) | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 59 | hsa00040 | Pentose and glucuronate interconversions - Homo sapiens (human) | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 60 | 162592 | Integration of provirus | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 61 | 180786 | Extension of Telomeres | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 62 | 174417 | Telomere C-strand (Lagging Strand) Synthesis | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 63 | 176187 | Activation of ATR in response to replication stress | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 64 | 73933 | Resolution of Abasic Sites (AP sites) | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 65 | 174437 | Removal of the Flap Intermediate from the C-strand | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 66 | 69183 | Processive synthesis on the lagging strand | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 67 | 76000 | Assembly of the RAD51-ssDNA nucleoprotein complex | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 68 | 73884 | Base Excision Repair | 2 | 397 | 2 | 0 | 0 | 0 | 555 | 0.17 | 0.01 | 0.00 | bZero |
| 69 | 71406 | Pyruvate metabolism and TCA cycle | 6 | 393 | 5 | 1 | 2 | 3 | 552 | 0.18 | 0.02 | 0.01 | 2.8 |
| 70 | hsa05223 | Non-small cell lung cancer - Homo sapiens (human) | 16 | 383 | 8 | 8 | 5 | 13 | 542 | 0.18 | 0.04 | 0.02 | 1.7 |
| 71 | hsa04916 | Melanogenesis - Homo sapiens (human) | 12 | 387 | 6 | 6 | 3 | 9 | 546 | 0.18 | 0.03 | 0.02 | 1.9 |
| 72 | 198203 | PI3K/AKT signalling | 9 | 390 | 4 | 5 | 1 | 6 | 549 | 0.19 | 0.02 | 0.01 | 2.1 |
| 73 | hsa04920 | Adipocytokine signaling pathway - Homo sapiens (human) | 9 | 390 | 0 | 9 | 12 | 21 | 534 | 0.19 | 0.02 | 0.04 | 0.6 |
| 74 | hsa05218 | Melanoma - Homo sapiens (human) | 17 | 382 | 9 | 8 | 7 | 15 | 540 | 0.20 | 0.04 | 0.03 | 1.6 |
| 75 | 163200 | Electron Transport Chain | 10 | 389 | 8 | 2 | 5 | 7 | 548 | 0.21 | 0.03 | 0.01 | 2.0 |
| 76 | hsa00251 | Glutamate metabolism - Homo sapiens (human) | 7 | 392 | 4 | 3 | 1 | 4 | 551 | 0.22 | 0.02 | 0.01 | 2.4 |
| 77 | hsa04720 | Long-term potentiation - Homo sapiens (human) | 10 | 389 | 4 | 6 | 2 | 8 | 547 | 0.24 | 0.03 | 0.01 | 1.7 |
| 78 | 76005 | Response to elevated platelet cytosolic Ca++ | 5 | 394 | 0 | 5 | 9 | 14 | 541 | 0.24 | 0.01 | 0.03 | 0.5 |
| 79 | 170984 | ARMS-mediated activation | 4 | 395 | 2 | 2 | 0 | 2 | 553 | 0.24 | 0.01 | 0.00 | 2.8 |
| 80 | 169893 | Prolonged ERK activation events | 4 | 395 | 2 | 2 | 0 | 2 | 553 | 0.24 | 0.01 | 0.00 | 2.8 |
| 81 | 170968 | Frs2-mediated activation | 4 | 395 | 2 | 2 | 0 | 2 | 553 | 0.24 | 0.01 | 0.00 | 2.8 |
| 82 | 71403 | Citric acid cycle (TCA cycle) | 4 | 395 | 3 | 1 | 1 | 2 | 553 | 0.24 | 0.01 | 0.00 | 2.8 |
| 83 | 187706 | Signalling to p38 via RIT and RIN | 4 | 395 | 2 | 2 | 0 | 2 | 553 | 0.24 | 0.01 | 0.00 | 2.8 |
| 84 | 71408 | Metabolism of small molecules | 4 | 395 | 2 | 2 | 0 | 2 | 553 | 0.24 | 0.01 | 0.00 | 2.8 |
| 85 | 69615 | G1/S DNA Damage Checkpoints | 4 | 395 | 2 | 2 | 0 | 2 | 553 | 0.24 | 0.01 | 0.00 | 2.8 |
| 86 | 77388 | SHC-related events | 4 | 395 | 2 | 2 | 0 | 2 | 553 | 0.24 | 0.01 | 0.00 | 2.8 |
| 87 | 190236 | Signaling by FGFR | 1 | 398 | 0 | 1 | 5 | 6 | 549 | 0.25 | 0.00 | 0.01 | 0.2 |
| 88 | 190376 | FGFR ligand binding and activation | 1 | 398 | 0 | 1 | 5 | 6 | 549 | 0.25 | 0.00 | 0.01 | 0.2 |
| 89 | 74751 | Insulin receptor signalling cascade | 7 | 392 | 3 | 4 | 1 | 5 | 550 | 0.26 | 0.02 | 0.01 | 1.9 |
| 90 | 77389 | IRS-related events | 7 | 392 | 3 | 4 | 1 | 5 | 550 | 0.26 | 0.02 | 0.01 | 1.9 |
| 91 | 109606 | Intrinsic Pathway for Apoptosis | 11 | 388 | 3 | 8 | 1 | 9 | 546 | 0.26 | 0.03 | 0.02 | 1.7 |
| 92 | hsa05210 | Colorectal cancer - Homo sapiens (human) | 21 | 378 | 8 | 13 | 7 | 20 | 535 | 0.26 | 0.05 | 0.04 | 1.5 |
| 93 | 194138 | Signaling by VEGF | 3 | 396 | 0 | 3 | 7 | 10 | 545 | 0.26 | 0.01 | 0.02 | 0.4 |
| 94 | hsa00340 | Histidine metabolism - Homo sapiens (human) | 5 | 394 | 3 | 2 | 1 | 3 | 552 | 0.29 | 0.01 | 0.01 | 2.3 |
| 95 | hsa00562 | Inositol phosphate metabolism - Homo sapiens (human) | 5 | 394 | 2 | 3 | 0 | 3 | 552 | 0.29 | 0.01 | 0.01 | 2.3 |
| 96 | 162909 | Host Interactions of HIV factors | 5 | 394 | 2 | 3 | 0 | 3 | 552 | 0.29 | 0.01 | 0.01 | 2.3 |
| 97 | hsa00260 | Glycine, serine and threonine metabolism - Homo sapiens (human) | 5 | 394 | 4 | 1 | 2 | 3 | 552 | 0.29 | 0.01 | 0.01 | 2.3 |
| 98 | 73923 | Lipid and lipoprotein metabolism | 7 | 392 | 4 | 3 | 13 | 16 | 539 | 0.29 | 0.02 | 0.03 | 0.6 |
| 99 | 74752 | Signaling by Insulin receptor | 9 | 390 | 4 | 5 | 2 | 7 | 548 | 0.31 | 0.02 | 0.01 | 1.8 |
| 100 | 15869 | Nucleotide metabolism | 9 | 390 | 3 | 6 | 1 | 7 | 548 | 0.31 | 0.02 | 0.01 | 1.8 |
| 101 | 69304 | Regulation of DNA replication | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 102 | 69052 | Switching of origins to a post-replicative state | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 103 | 156902 | Peptide chain elongation | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 104 | 69580 | p53-Dependent G1/S DNA damage checkpoint | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 105 | 72766 | Translation | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 106 | 112410 | SHC-mediated signalling | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 107 | 156842 | Eukaryotic Translation Elongation | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 108 | 162594 | Early Phase of HIV Life Cycle | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 109 | hsa00930 | Caprolactam degradation - Homo sapiens (human) | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 110 | 71397 | Oxidative decarboxylation of pyruvate to acetyl CoA by pyruvate dehydrogenase | 3 | 396 | 3 | 0 | 1 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 111 | 180292 | Gab1 signalosome | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 112 | 69206 | G1/S Transition | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 113 | 112412 | SOS-mediated signalling | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 114 | 109869 | MAP kinase cascade | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 115 | hsa00500 | Starch and sucrose metabolism - Homo sapiens (human) | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 116 | 69563 | p53-Dependent G1 DNA Damage Response | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 117 | 204174 | Regulation of pyruvate dehydrogenase complex (PDC) | 3 | 396 | 3 | 0 | 1 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 118 | hsa00120 | Bile acid biosynthesis - Homo sapiens (human) | 3 | 396 | 3 | 0 | 1 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 119 | 68949 | Orc1 removal from chromatin | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 120 | 69300 | Removal of licensing factors from origins | 3 | 396 | 2 | 1 | 0 | 1 | 554 | 0.31 | 0.01 | 0.00 | 4.2 |
| 121 | hsa04910 | Insulin signaling pathway - Homo sapiens (human) | 19 | 380 | 7 | 12 | 7 | 19 | 536 | 0.32 | 0.05 | 0.03 | 1.4 |
| 122 | 198933 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 2 | 397 | 0 | 2 | 5 | 7 | 548 | 0.32 | 0.01 | 0.01 | 0.4 |
| 123 | hsa04730 | Long-term depression - Homo sapiens (human) | 14 | 385 | 3 | 11 | 2 | 13 | 542 | 0.32 | 0.04 | 0.02 | 1.5 |
| 124 | hsa04360 | Axon guidance - Homo sapiens (human) | 5 | 394 | 1 | 4 | 8 | 12 | 543 | 0.33 | 0.01 | 0.02 | 0.6 |
| 125 | 167044 | Signalling to RAS | 6 | 393 | 3 | 3 | 1 | 4 | 551 | 0.34 | 0.02 | 0.01 | 2.1 |
| 126 | 112399 | IRS-mediated signalling | 6 | 393 | 3 | 3 | 1 | 4 | 551 | 0.34 | 0.02 | 0.01 | 2.1 |
| 127 | hsa05020 | Parkinson's disease - Homo sapiens (human) | 6 | 393 | 3 | 3 | 1 | 4 | 551 | 0.34 | 0.02 | 0.01 | 2.1 |
| 128 | 187687 | Signalling to ERKs | 6 | 393 | 3 | 3 | 1 | 4 | 551 | 0.34 | 0.02 | 0.01 | 2.1 |
| 129 | hsa00360 | Phenylalanine metabolism - Homo sapiens (human) | 6 | 393 | 4 | 2 | 2 | 4 | 551 | 0.34 | 0.02 | 0.01 | 2.1 |
| 130 | hsa00380 | Tryptophan metabolism - Homo sapiens (human) | 6 | 393 | 4 | 2 | 2 | 4 | 551 | 0.34 | 0.02 | 0.01 | 2.1 |
| 131 | hsa04912 | GnRH signaling pathway - Homo sapiens (human) | 15 | 384 | 7 | 8 | 6 | 14 | 541 | 0.34 | 0.04 | 0.03 | 1.5 |
| 132 | hsa05030 | Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human) | 15 | 384 | 1 | 14 | 0 | 14 | 541 | 0.34 | 0.04 | 0.03 | 1.5 |
| 133 | hsa04530 | Tight junction - Homo sapiens (human) | 10 | 389 | 4 | 6 | 3 | 9 | 546 | 0.36 | 0.03 | 0.02 | 1.5 |
| 134 | hsa04662 | B cell receptor signaling pathway - Homo sapiens (human) | 10 | 389 | 2 | 8 | 1 | 9 | 546 | 0.36 | 0.03 | 0.02 | 1.5 |
| 135 | hsa05211 | Renal cell carcinoma - Homo sapiens (human) | 11 | 388 | 4 | 7 | 15 | 22 | 533 | 0.37 | 0.03 | 0.04 | 0.7 |
| 136 | hsa04210 | Apoptosis - Homo sapiens (human) | 32 | 367 | 7 | 25 | 11 | 36 | 519 | 0.37 | 0.08 | 0.06 | 1.2 |
| 137 | hsa01510 | Neurodegenerative Diseases - Homo sapiens (human) | 25 | 374 | 4 | 21 | 6 | 27 | 528 | 0.39 | 0.06 | 0.05 | 1.3 |
| 138 | 177929 | Signaling by EGFR | 7 | 392 | 4 | 3 | 3 | 6 | 549 | 0.41 | 0.02 | 0.01 | 1.6 |
| 139 | 163685 | Integration of energy metabolism | 7 | 392 | 4 | 3 | 3 | 6 | 549 | 0.41 | 0.02 | 0.01 | 1.6 |
| 140 | 202733 | Cell surface interactions at the vascular wall | 7 | 392 | 4 | 3 | 3 | 6 | 549 | 0.41 | 0.02 | 0.01 | 1.6 |
| 141 | 168176 | Toll Like Receptor 5 (TLR5) Cascade | 1 | 398 | 1 | 0 | 4 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 142 | 166058 | MyD88 cascade | 1 | 398 | 1 | 0 | 4 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 143 | 168142 | Toll Like Receptor 10 (TLR10) Cascade | 1 | 398 | 1 | 0 | 4 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 144 | 168188 | Toll Like Receptor TLR6:TLR2 Cascade | 1 | 398 | 1 | 0 | 4 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 145 | 181438 | Toll Like Receptor 2 Cascade | 1 | 398 | 1 | 0 | 4 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 146 | 168179 | Toll Like Receptor TLR1:TLR2 Cascade | 1 | 398 | 1 | 0 | 4 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 147 | hsa00361 | gamma-Hexachlorocyclohexane degradation - Homo sapiens (human) | 1 | 398 | 0 | 1 | 3 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 148 | 168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 1 | 398 | 1 | 0 | 4 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 149 | 195721 | Signaling by Wnt | 1 | 398 | 1 | 0 | 4 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 150 | 166054 | Activated TLR4 signalling | 1 | 398 | 1 | 0 | 4 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 151 | 190322 | FGFR4 ligand binding and activation | 1 | 398 | 0 | 1 | 3 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 152 | 166016 | Toll Like Receptor 4 (TLR4) Cascade | 1 | 398 | 1 | 0 | 4 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 153 | 140181 | Cytochrome p450 | 1 | 398 | 0 | 1 | 3 | 4 | 551 | 0.41 | 0.00 | 0.01 | 0.3 |
| 154 | 174800 | Chylomicron-mediated lipid transport | 1 | 398 | 0 | 1 | 4 | 5 | 550 | 0.41 | 0.00 | 0.01 | 0.3 |
| 155 | 190241 | FGFR2 ligand binding and activation | 1 | 398 | 0 | 1 | 4 | 5 | 550 | 0.41 | 0.00 | 0.01 | 0.3 |
| 156 | 190375 | FGFR2c ligand binding and activation | 1 | 398 | 0 | 1 | 4 | 5 | 550 | 0.41 | 0.00 | 0.01 | 0.3 |
| 157 | 190242 | FGFR1 ligand binding and activation | 1 | 398 | 0 | 1 | 4 | 5 | 550 | 0.41 | 0.00 | 0.01 | 0.3 |
| 158 | 190373 | FGFR1c ligand binding and activation | 1 | 398 | 0 | 1 | 4 | 5 | 550 | 0.41 | 0.00 | 0.01 | 0.3 |
| 159 | 174824 | Lipoprotein metabolism | 1 | 398 | 0 | 1 | 4 | 5 | 550 | 0.41 | 0.00 | 0.01 | 0.3 |
| 160 | 168138 | Toll Like Receptor 9 (TLR9) Cascade | 1 | 398 | 1 | 0 | 5 | 5 | 550 | 0.41 | 0.00 | 0.01 | 0.3 |
| 161 | 168769 | BoNT Light Chain Types B, D, and F cleave VAMP/Synaptobrevin | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 162 | 168273 | Influenza Viral RNA Transcription and Replication | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 163 | 73728 | RNA Polymerase I Promoter Opening | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 164 | 70172 | Phosphorylase kinase activates glycogen phosphorylase | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 165 | 109979 | Gap-filling DNA repair synthesis and ligation in TC-NER | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 166 | 191650 | Regulation of gap junction activity | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 167 | 74969 | Gap-filling DNA repair synthesis and ligation in GG-NER | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 168 | 168255 | Influenza Life Cycle | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 169 | 174403 | Glutathione synthesis | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 170 | 188108 | MyD88 Cascade (Murine) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 171 | 164843 | 2-LTR circle formation | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 172 | 73621 | Pyrimidine catabolism | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 173 | 159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 174 | 180897 | Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 175 | 68962 | Activation of the pre-replicative complex | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 176 | hsa00950 | Alkaloid biosynthesis I - Homo sapiens (human) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 177 | hsa03030 | DNA replication - Homo sapiens (human) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 178 | hsa00770 | Pantothenate and CoA biosynthesis - Homo sapiens (human) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 179 | 171306 | Packaging Of Telomere Ends | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 180 | 162585 | Uncoating of the HIV Virion | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 181 | 83542 | ATM mediated response to DNA double-strand break | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 182 | 168782 | Proteolytic cleavage of SNARE complex proteins | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 183 | 112407 | RAF phosphorylates MEK | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 184 | 71336 | Pentose phosphate pathway (hexose monophosphate shunt) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 185 | 168799 | Botulinum neurotoxicity | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 186 | 70845 | Isoleucine catabolism | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 187 | 180689 | APOBEC3G mediated resistance to HIV-1 infection | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 188 | 71037 | Oxidative decarboxylation of alpha-ketoadipate to glutaryl CoA by alpha-ketoglutarate dehydrogenase | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 189 | 69091 | Polymerase switching | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 190 | 71383 | Acetate, ATP, and coenzyme A react to form acetyl CoA, AMP, and pyrophosphate | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 191 | 110049 | MEK activation | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 192 | 168325 | Viral Messenger RNA Synthesis | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 193 | 73930 | Base-free sugar-phosphate removal via the single-nucleotide replacement pathway | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 194 | 73927 | Depurination | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 195 | 69109 | Leading Strand Synthesis | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 196 | 68886 | M Phase | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 197 | 176033 | Interactions of Vpr with host cellular proteins | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 198 | 71064 | Lysine catabolism | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 199 | 71338 | Ethanol is oxidized by NAD+ to form acetaldehyde, NADH, and H+ | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 200 | hsa00740 | Riboflavin metabolism - Homo sapiens (human) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 201 | hsa00460 | Cyanoamino acid metabolism - Homo sapiens (human) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 202 | 114294 | Activation, translocation and oligomerization of BAX | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 203 | 162589 | Reverse Transcription of HIV RNA | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 204 | 70853 | Oxidative decarboxylation of alpha-ketoisovalerate to isobutyryl-CoA by branched-chain alpha-ketoacid dehydrogenase | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 205 | 77378 | Formation of Cytosolic Glycerol-3-phosphate | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 206 | 110056 | ERK1 activation | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 207 | 68875 | Mitotic Prophase | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 208 | 164525 | Plus-strand DNA synthesis | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 209 | 163358 | PKA-mediated phosphorylation of key metabolic factors | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 210 | 73929 | Base-Excision Repair, AP Site Formation | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 211 | hsa01030 | Glycan structures - biosynthesis 1 - Homo sapiens (human) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 212 | 109977 | Repair synthesis for gap-filling by DNA polymerase in TC-NER | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 213 | 192456 | Digestion of dietary lipid | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 214 | 174411 | Polymerase switching on the C-strand of the telomere | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 215 | 110381 | Resolution of AP sites via the single-nucleotide replacement pathway | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 216 | 163560 | Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 217 | hsa00052 | Galactose metabolism - Homo sapiens (human) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 218 | 210991 | Basigin interactions | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 219 | 69473 | G2/M DNA damage checkpoint | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 220 | 71401 | Oxidative decarboxylation of alpha-ketoglutarate to succinyl CoA by alpha-ketoglutarate dehydrogenase | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 221 | 110330 | Recognition and association of DNA glycosylase with site containing an affected purine | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 222 | 164516 | Minus-strand DNA synthesis | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 223 | hsa00030 | Pentose phosphate pathway - Homo sapiens (human) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 224 | 111452 | Activation and oligomerization of BAK protein | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 225 | 142045 | Alcohol Dehydrogenase | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 226 | hsa00510 | N-Glycan biosynthesis - Homo sapiens (human) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 227 | 71182 | Phenylalanine and tyrosine catabolism | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 228 | 142033 | Ethanol Catabolism | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 229 | 110331 | Cleavage of the damaged purine | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 230 | 70726 | Oxidative decarboxylation of alpha-ketoisocaproate to isovaleryl-CoA by branched-chain alpha-ketoacid dehydrogenase | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 231 | hsa04130 | SNARE interactions in vesicular transport - Homo sapiens (human) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 232 | 188081 | Toll Like Receptor 11 (TLR11) Cascade (Murine) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 233 | 74967 | Repair synthesis of patch ~27-30 bases long by DNA polymerase | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 234 | hsa00051 | Fructose and mannose metabolism - Homo sapiens (human) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 235 | 176974 | Unwinding of DNA | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 236 | 71032 | Propionyl-CoA catabolism | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 237 | 187577 | SCF(Skp2)-mediated degradation of p27/p21 | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 238 | 110357 | Displacement of DNA glycosylase by APE1 | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 239 | 70221 | Glycogen breakdown (glycogenolysis) | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 240 | 75148 | ATM mediated phosphorylation of repair proteins | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 241 | 162658 | Golgi Cisternae Pericentriolar Stack Reorganization | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 242 | 191647 | c-src mediated regulation of Cx43 function and closure of gap junctions | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 243 | 70794 | Oxidative decarboxylation of alpha-keto-beta-methylvalerate to alpha-methylbutyryl-CoA by branched-chain alpha-ketoacid dehydrogenase | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 244 | 75894 | Synthesis of lysophosphatidic acid from glycerol-3-phosphate | 1 | 398 | 1 | 0 | 0 | 0 | 555 | 0.42 | 0.00 | 0.00 | bZero |
| 245 | hsa04370 | VEGF signaling pathway - Homo sapiens (human) | 20 | 379 | 6 | 14 | 7 | 21 | 534 | 0.42 | 0.05 | 0.04 | 1.3 |
| 246 | hsa05221 | Acute myeloid leukemia - Homo sapiens (human) | 13 | 386 | 5 | 8 | 5 | 13 | 542 | 0.42 | 0.03 | 0.02 | 1.4 |
| 247 | 109582 | Hemostasis | 17 | 382 | 6 | 11 | 19 | 30 | 525 | 0.45 | 0.04 | 0.05 | 0.8 |
| 248 | 194840 | Rho GTPase cycle | 4 | 395 | 2 | 2 | 1 | 3 | 552 | 0.46 | 0.01 | 0.01 | 1.9 |
| 249 | 202131 | Metabolism of nitric oxide | 4 | 395 | 1 | 3 | 0 | 3 | 552 | 0.46 | 0.01 | 0.01 | 1.9 |
| 250 | 114509 | Platelet activation triggers | 4 | 395 | 1 | 3 | 0 | 3 | 552 | 0.46 | 0.01 | 0.01 | 1.9 |
| 251 | hsa00252 | Alanine and aspartate metabolism - Homo sapiens (human) | 4 | 395 | 4 | 0 | 3 | 3 | 552 | 0.46 | 0.01 | 0.01 | 1.9 |
| 252 | 76002 | Platelet Activation | 4 | 395 | 1 | 3 | 0 | 3 | 552 | 0.46 | 0.01 | 0.01 | 1.9 |
| 253 | 71387 | Metabolism of carbohydrates | 4 | 395 | 2 | 2 | 1 | 3 | 552 | 0.46 | 0.01 | 0.01 | 1.9 |
| 254 | 198725 | Nuclear Events (kinase and transcription factor activation) | 4 | 395 | 1 | 3 | 0 | 3 | 552 | 0.46 | 0.01 | 0.01 | 1.9 |
| 255 | 164378 | PKA activation in glucagon signalling | 4 | 395 | 1 | 3 | 0 | 3 | 552 | 0.46 | 0.01 | 0.01 | 1.9 |
| 256 | hsa00410 | beta-Alanine metabolism - Homo sapiens (human) | 4 | 395 | 3 | 1 | 2 | 3 | 552 | 0.46 | 0.01 | 0.01 | 1.9 |
| 257 | hsa05215 | Prostate cancer - Homo sapiens (human) | 23 | 376 | 9 | 14 | 12 | 26 | 529 | 0.46 | 0.06 | 0.05 | 1.2 |
| 258 | 75153 | Apoptotic execution phase | 2 | 397 | 0 | 2 | 4 | 6 | 549 | 0.48 | 0.01 | 0.01 | 0.5 |
| 259 | 111465 | Cleavage of cellular proteins by active caspases | 2 | 397 | 0 | 2 | 4 | 6 | 549 | 0.48 | 0.01 | 0.01 | 0.5 |
| 260 | 202403 | TCR signaling | 9 | 390 | 2 | 7 | 2 | 9 | 546 | 0.48 | 0.02 | 0.02 | 1.4 |
| 261 | 162906 | HIV Infection | 9 | 390 | 5 | 4 | 5 | 9 | 546 | 0.48 | 0.02 | 0.02 | 1.4 |
| 262 | hsa04930 | Type II diabetes mellitus - Homo sapiens (human) | 9 | 390 | 3 | 6 | 3 | 9 | 546 | 0.48 | 0.02 | 0.02 | 1.4 |
| 263 | hsa04010 | MAPK signaling pathway - Homo sapiens (human) | 37 | 362 | 9 | 28 | 16 | 44 | 511 | 0.48 | 0.09 | 0.08 | 1.2 |
| 264 | hsa04664 | Fc epsilon RI signaling pathway - Homo sapiens (human) | 17 | 382 | 5 | 12 | 6 | 18 | 537 | 0.49 | 0.04 | 0.03 | 1.3 |
| 265 | hsa04810 | Regulation of actin cytoskeleton - Homo sapiens (human) | 13 | 386 | 5 | 8 | 16 | 24 | 531 | 0.50 | 0.03 | 0.04 | 0.8 |
| 266 | hsa00561 | Glycerolipid metabolism - Homo sapiens (human) | 5 | 394 | 5 | 0 | 4 | 4 | 551 | 0.50 | 0.01 | 0.01 | 1.7 |
| 267 | hsa04660 | T cell receptor signaling pathway - Homo sapiens (human) | 18 | 381 | 3 | 15 | 5 | 20 | 535 | 0.51 | 0.05 | 0.04 | 1.3 |
| 268 | hsa04670 | Leukocyte transendothelial migration - Homo sapiens (human) | 14 | 385 | 3 | 11 | 14 | 25 | 530 | 0.51 | 0.04 | 0.05 | 0.8 |
| 269 | hsa00980 | Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human) | 3 | 396 | 1 | 2 | 5 | 7 | 548 | 0.53 | 0.01 | 0.01 | 0.6 |
| 270 | 194313 | VEGF ligand-receptor interactions | 3 | 396 | 0 | 3 | 4 | 7 | 548 | 0.53 | 0.01 | 0.01 | 0.6 |
| 271 | 168180 | TRAF6 Mediated Induction of the antiviral cytokine IFN-alpha/beta cascade | 6 | 393 | 1 | 5 | 0 | 5 | 550 | 0.54 | 0.02 | 0.01 | 1.7 |
| 272 | 168164 | Toll Like Receptor 3 (TLR3) Cascade | 6 | 393 | 1 | 5 | 0 | 5 | 550 | 0.54 | 0.02 | 0.01 | 1.7 |
| 273 | hsa00230 | Purine metabolism - Homo sapiens (human) | 6 | 393 | 3 | 3 | 2 | 5 | 550 | 0.54 | 0.02 | 0.01 | 1.7 |
| 274 | 75178 | Formation of Platelet plug | 9 | 390 | 1 | 8 | 9 | 17 | 538 | 0.55 | 0.02 | 0.03 | 0.7 |
| 275 | 73847 | Purine metabolism | 6 | 393 | 1 | 5 | 1 | 6 | 549 | 0.57 | 0.02 | 0.01 | 1.4 |
| 276 | hsa01430 | Cell Communication - Homo sapiens (human) | 4 | 395 | 1 | 3 | 6 | 9 | 546 | 0.57 | 0.01 | 0.02 | 0.6 |
| 277 | 202670 | ERKs are inactivated | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 278 | 68867 | Assembly of the pre-replicative complex | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 279 | 69202 | Cyclin E associated events during G1/S transition | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 280 | 210993 | Tie2 Signaling | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 281 | 72613 | Eukaryotic Translation Initiation | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 282 | 69236 | G1 Phase | 2 | 397 | 2 | 0 | 1 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 283 | 70894 | Valine catabolism | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 284 | hsa00641 | 3-Chloroacrylic acid degradation - Homo sapiens (human) | 2 | 397 | 2 | 0 | 1 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 285 | 173107 | Binding and entry of HIV virion | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 286 | 111742 | Reduction of cytosolic ribonucleoside 5'-diphosphates to deoxyribonucleoside 5'-diphosphates (glutaredoxin) | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 287 | 156590 | Glutathione conjugation | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 288 | 156580 | Phase II conjugation | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 289 | hsa00630 | Glyoxylate and dicarboxylate metabolism - Homo sapiens (human) | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 290 | 157279 | 3' -UTR-mediated translational regulation | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 291 | hsa00720 | Reductive carboxylate cycle (CO2 fixation) - Homo sapiens (human) | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 292 | 114604 | Collagen-mediated activation cascade | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 293 | 69002 | DNA Replication Pre-Initiation | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 294 | 72737 | Cap-dependent Translation Initiation | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 295 | 68874 | M/G1 Transition | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 296 | 69231 | Cyclin D associated events in G1 | 2 | 397 | 2 | 0 | 1 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 297 | 72764 | Eukaryotic Translation Termination | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 298 | 111747 | Reduction of cytosolic ribonucleoside 5'-diphosphates to deoxyribonucleoside 5'-diphosphates by ribonucleotide reductase and glutaredoxin | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 299 | 74749 | Signal attenuation | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 300 | 171007 | p38MAPK events | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 301 | 69656 | Cyclin A:Cdk2-associated events at S phase entry | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 302 | hsa00600 | Sphingolipid metabolism - Homo sapiens (human) | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 303 | 112409 | ERK activation | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 304 | 69541 | Stabilization of p53 | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 305 | 72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 306 | 72689 | Formation of a pool of free 40S subunits | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 307 | 156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 2 | 397 | 1 | 1 | 0 | 1 | 554 | 0.57 | 0.01 | 0.00 | 2.8 |
| 308 | 74160 | Gene Expression | 7 | 392 | 4 | 3 | 4 | 7 | 548 | 0.59 | 0.02 | 0.01 | 1.4 |
| 309 | hsa05060 | Prion disease - Homo sapiens (human) | 7 | 392 | 1 | 6 | 1 | 7 | 548 | 0.59 | 0.02 | 0.01 | 1.4 |
| 310 | 71291 | Metabolism of amino acids | 7 | 392 | 4 | 3 | 4 | 7 | 548 | 0.59 | 0.02 | 0.01 | 1.4 |
| 311 | hsa05216 | Thyroid cancer - Homo sapiens (human) | 7 | 392 | 3 | 4 | 3 | 7 | 548 | 0.59 | 0.02 | 0.01 | 1.4 |
| 312 | hsa04640 | Hematopoietic cell lineage - Homo sapiens (human) | 12 | 387 | 2 | 10 | 11 | 21 | 534 | 0.59 | 0.03 | 0.04 | 0.8 |
| 313 | 202424 | Downstream TCR signaling | 8 | 391 | 2 | 6 | 2 | 8 | 547 | 0.61 | 0.02 | 0.01 | 1.4 |
| 314 | hsa05212 | Pancreatic cancer - Homo sapiens (human) | 20 | 379 | 9 | 11 | 13 | 24 | 531 | 0.64 | 0.05 | 0.04 | 1.2 |
| 315 | hsa00903 | Limonene and pinene degradation - Homo sapiens (human) | 1 | 398 | 1 | 0 | 3 | 3 | 552 | 0.64 | 0.00 | 0.01 | 0.5 |
| 316 | hsa04950 | Maturity onset diabetes of the young - Homo sapiens (human) | 1 | 398 | 0 | 1 | 2 | 3 | 552 | 0.64 | 0.00 | 0.01 | 0.5 |
| 317 | hsa04614 | Renin-angiotensin system - Homo sapiens (human) | 1 | 398 | 0 | 1 | 2 | 3 | 552 | 0.64 | 0.00 | 0.01 | 0.5 |
| 318 | 164385 | G(s)-alpha mediated events in glucagon signalling | 1 | 398 | 0 | 1 | 2 | 3 | 552 | 0.64 | 0.00 | 0.01 | 0.5 |
| 319 | 190239 | FGFR3 ligand binding and activation | 1 | 398 | 0 | 1 | 2 | 3 | 552 | 0.64 | 0.00 | 0.01 | 0.5 |
| 320 | 157858 | Gap junction trafficking and regulation | 1 | 398 | 1 | 0 | 3 | 3 | 552 | 0.64 | 0.00 | 0.01 | 0.5 |
| 321 | 190372 | FGFR3c ligand binding and activation | 1 | 398 | 0 | 1 | 2 | 3 | 552 | 0.64 | 0.00 | 0.01 | 0.5 |
| 322 | 111748 | Synthesis of deoxyribonucleoside 5'-diphosphates from ribonucleoside 5'-diphosphates | 3 | 396 | 1 | 2 | 0 | 2 | 553 | 0.65 | 0.01 | 0.00 | 2.1 |
| 323 | 73848 | Pyrimidine metabolism | 3 | 396 | 1 | 2 | 0 | 2 | 553 | 0.65 | 0.01 | 0.00 | 2.1 |
| 324 | 70326 | Glucose metabolism | 3 | 396 | 1 | 2 | 0 | 2 | 553 | 0.65 | 0.01 | 0.00 | 2.1 |
| 325 | hsa04320 | Dorso-ventral axis formation - Homo sapiens (human) | 3 | 396 | 2 | 1 | 1 | 2 | 553 | 0.65 | 0.01 | 0.00 | 2.1 |
| 326 | 198323 | AKT phosphorylates targets in the cytosol | 3 | 396 | 2 | 1 | 1 | 2 | 553 | 0.65 | 0.01 | 0.00 | 2.1 |
| 327 | 111458 | Formation of apoptosome | 3 | 396 | 1 | 2 | 0 | 2 | 553 | 0.65 | 0.01 | 0.00 | 2.1 |
| 328 | 203615 | eNOS activation | 3 | 396 | 1 | 2 | 0 | 2 | 553 | 0.65 | 0.01 | 0.00 | 2.1 |
| 329 | hsa00240 | Pyrimidine metabolism - Homo sapiens (human) | 3 | 396 | 2 | 1 | 1 | 2 | 553 | 0.65 | 0.01 | 0.00 | 2.1 |
| 330 | 199418 | Negative regulation of the PI3K/AKT network | 3 | 396 | 1 | 2 | 0 | 2 | 553 | 0.65 | 0.01 | 0.00 | 2.1 |
| 331 | 203765 | eNOS activation and regulation | 3 | 396 | 1 | 2 | 0 | 2 | 553 | 0.65 | 0.01 | 0.00 | 2.1 |
| 332 | 198753 | ERK/MAPK targets | 3 | 396 | 1 | 2 | 0 | 2 | 553 | 0.65 | 0.01 | 0.00 | 2.1 |
| 333 | hsa04540 | Gap junction - Homo sapiens (human) | 11 | 388 | 7 | 4 | 9 | 13 | 542 | 0.68 | 0.03 | 0.02 | 1.2 |
| 334 | 162587 | HIV Life Cycle | 3 | 396 | 2 | 1 | 2 | 3 | 552 | 0.70 | 0.01 | 0.01 | 1.4 |
| 335 | 74226 | ATP formation | 3 | 396 | 1 | 2 | 1 | 3 | 552 | 0.70 | 0.01 | 0.01 | 1.4 |
| 336 | 111463 | SMAC binds to IAPs | 3 | 396 | 1 | 2 | 1 | 3 | 552 | 0.70 | 0.01 | 0.01 | 1.4 |
| 337 | 109704 | PI3K Cascade | 3 | 396 | 1 | 2 | 1 | 3 | 552 | 0.70 | 0.01 | 0.01 | 1.4 |
| 338 | 114452 | Activation of BH3-only proteins | 3 | 396 | 0 | 3 | 0 | 3 | 552 | 0.70 | 0.01 | 0.01 | 1.4 |
| 339 | 111469 | SMAC-mediated apoptotic response | 3 | 396 | 1 | 2 | 1 | 3 | 552 | 0.70 | 0.01 | 0.01 | 1.4 |
| 340 | 111464 | SMAC-mediated dissociation of IAP:caspase complexes | 3 | 396 | 1 | 2 | 1 | 3 | 552 | 0.70 | 0.01 | 0.01 | 1.4 |
| 341 | 75983 | Formation and Maturation of mRNA Transcript | 2 | 397 | 1 | 1 | 4 | 5 | 550 | 0.71 | 0.01 | 0.01 | 0.6 |
| 342 | 196849 | Metabolism of water-soluble vitamins and cofactors | 2 | 397 | 1 | 1 | 4 | 5 | 550 | 0.71 | 0.01 | 0.01 | 0.6 |
| 343 | 196854 | Metabolism of vitamins and cofactors | 2 | 397 | 1 | 1 | 4 | 5 | 550 | 0.71 | 0.01 | 0.01 | 0.6 |
| 344 | 194315 | Signaling by Rho GTPases | 4 | 395 | 2 | 2 | 2 | 4 | 551 | 0.73 | 0.01 | 0.01 | 1.4 |
| 345 | 111459 | Activation of caspases through apoptosome-mediated cleavage | 4 | 395 | 1 | 3 | 1 | 4 | 551 | 0.73 | 0.01 | 0.01 | 1.4 |
| 346 | hsa00220 | Urea cycle and metabolism of amino groups - Homo sapiens (human) | 4 | 395 | 3 | 1 | 3 | 4 | 551 | 0.73 | 0.01 | 0.01 | 1.4 |
| 347 | 75157 | FasL/ CD95L signaling | 4 | 395 | 0 | 4 | 0 | 4 | 551 | 0.73 | 0.01 | 0.01 | 1.4 |
| 348 | hsa00860 | Porphyrin and chlorophyll metabolism - Homo sapiens (human) | 4 | 395 | 0 | 4 | 0 | 4 | 551 | 0.73 | 0.01 | 0.01 | 1.4 |
| 349 | 111461 | Cytochrome c-mediated apoptotic response | 4 | 395 | 1 | 3 | 1 | 4 | 551 | 0.73 | 0.01 | 0.01 | 1.4 |
| 350 | hsa04512 | ECM-receptor interaction - Homo sapiens (human) | 3 | 396 | 2 | 1 | 5 | 6 | 549 | 0.74 | 0.01 | 0.01 | 0.7 |
| 351 | 140191 | Phase 1 functionalization | 5 | 394 | 3 | 2 | 3 | 5 | 550 | 0.75 | 0.01 | 0.01 | 1.4 |
| 352 | 74231 | Purine biosynthesis | 5 | 394 | 1 | 4 | 1 | 5 | 550 | 0.75 | 0.01 | 0.01 | 1.4 |
| 353 | 111471 | Apoptotic factor-mediated response | 5 | 394 | 1 | 4 | 1 | 5 | 550 | 0.75 | 0.01 | 0.01 | 1.4 |
| 354 | 109581 | Apoptosis | 19 | 380 | 4 | 15 | 9 | 24 | 531 | 0.75 | 0.05 | 0.04 | 1.1 |
| 355 | hsa04110 | Cell cycle - Homo sapiens (human) | 6 | 393 | 5 | 1 | 6 | 7 | 548 | 0.78 | 0.02 | 0.01 | 1.2 |
| 356 | hsa04510 | Focal adhesion - Homo sapiens (human) | 28 | 371 | 11 | 17 | 19 | 36 | 519 | 0.79 | 0.07 | 0.06 | 1.1 |
| 357 | 168898 | Toll Receptor Cascades | 8 | 391 | 3 | 5 | 5 | 10 | 545 | 0.81 | 0.02 | 0.02 | 1.1 |
| 358 | 168249 | Innate Immunity Signaling | 8 | 391 | 3 | 5 | 5 | 10 | 545 | 0.81 | 0.02 | 0.02 | 1.1 |
| 359 | hsa05219 | Bladder cancer - Homo sapiens (human) | 10 | 389 | 6 | 4 | 8 | 12 | 543 | 0.83 | 0.03 | 0.02 | 1.2 |
| 360 | hsa05040 | Huntington's disease - Homo sapiens (human) | 9 | 390 | 2 | 7 | 7 | 14 | 541 | 0.83 | 0.02 | 0.03 | 0.9 |
| 361 | hsa04650 | Natural killer cell mediated cytotoxicity - Homo sapiens (human) | 16 | 383 | 5 | 11 | 10 | 21 | 534 | 0.87 | 0.04 | 0.04 | 1.1 |
| 362 | 168256 | Signaling in Immune system | 24 | 375 | 10 | 14 | 18 | 32 | 523 | 0.89 | 0.06 | 0.06 | 1.0 |
| 363 | hsa04620 | Toll-like receptor signaling pathway - Homo sapiens (human) | 23 | 376 | 6 | 17 | 15 | 32 | 523 | 1.00 | 0.06 | 0.06 | 1.0 |
| 364 | hsa04310 | Wnt signaling pathway - Homo sapiens (human) | 11 | 388 | 3 | 8 | 7 | 15 | 540 | 1.00 | 0.03 | 0.03 | 1.0 |
| 365 | hsa04020 | Calcium signaling pathway - Homo sapiens (human) | 11 | 388 | 4 | 7 | 8 | 15 | 540 | 1.00 | 0.03 | 0.03 | 1.0 |
| 366 | hsa04150 | mTOR signaling pathway - Homo sapiens (human) | 10 | 389 | 3 | 7 | 7 | 14 | 541 | 1.00 | 0.03 | 0.03 | 1.0 |
| 367 | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human) | 10 | 389 | 1 | 9 | 5 | 14 | 541 | 1.00 | 0.03 | 0.03 | 1.0 |
| 368 | hsa04940 | Type I diabetes mellitus - Homo sapiens (human) | 10 | 389 | 1 | 9 | 4 | 13 | 542 | 1.00 | 0.03 | 0.02 | 1.1 |
| 369 | hsa05010 | Alzheimer's disease - Homo sapiens (human) | 10 | 389 | 1 | 9 | 6 | 15 | 540 | 1.00 | 0.03 | 0.03 | 0.9 |
| 370 | hsa04612 | Antigen processing and presentation - Homo sapiens (human) | 8 | 391 | 2 | 6 | 6 | 12 | 543 | 1.00 | 0.02 | 0.02 | 0.9 |
| 371 | hsa00590 | Arachidonic acid metabolism - Homo sapiens (human) | 7 | 392 | 2 | 5 | 6 | 11 | 544 | 1.00 | 0.02 | 0.02 | 0.9 |
| 372 | hsa04350 | TGF-beta signaling pathway - Homo sapiens (human) | 7 | 392 | 2 | 5 | 4 | 9 | 546 | 1.00 | 0.02 | 0.02 | 1.1 |
| 373 | hsa04520 | Adherens junction - Homo sapiens (human) | 6 | 393 | 3 | 3 | 6 | 9 | 546 | 1.00 | 0.02 | 0.02 | 0.9 |
| 374 | 73887 | Death Receptor Signalling | 5 | 394 | 0 | 5 | 3 | 8 | 547 | 1.00 | 0.01 | 0.01 | 0.9 |
| 375 | 74159 | Transcription | 5 | 394 | 3 | 2 | 4 | 6 | 549 | 1.00 | 0.01 | 0.01 | 1.2 |
| 376 | hsa05050 | Dentatorubropallidoluysian atrophy (DRPLA) - Homo sapiens (human) | 5 | 394 | 0 | 5 | 1 | 6 | 549 | 1.00 | 0.01 | 0.01 | 1.2 |
| 377 | hsa04120 | Ubiquitin mediated proteolysis - Homo sapiens (human) | 5 | 394 | 2 | 3 | 4 | 7 | 548 | 1.00 | 0.01 | 0.01 | 1.0 |
| 378 | 109607 | Extrinsic Pathway for Apoptosis | 5 | 394 | 0 | 5 | 3 | 8 | 547 | 1.00 | 0.01 | 0.01 | 0.9 |
| 379 | 163359 | Glucagon signaling in metabolic regulation | 4 | 395 | 1 | 3 | 2 | 5 | 550 | 1.00 | 0.01 | 0.01 | 1.1 |
| 380 | 140534 | Caspase-8 is formed from procaspase-8 | 4 | 395 | 0 | 4 | 2 | 6 | 549 | 1.00 | 0.01 | 0.01 | 0.9 |
| 381 | hsa05130 | Pathogenic Escherichia coli infection - EHEC - Homo sapiens (human) | 4 | 395 | 2 | 2 | 4 | 6 | 549 | 1.00 | 0.01 | 0.01 | 0.9 |
| 382 | hsa00330 | Arginine and proline metabolism - Homo sapiens (human) | 4 | 395 | 1 | 3 | 3 | 6 | 549 | 1.00 | 0.01 | 0.01 | 0.9 |
| 383 | hsa05131 | Pathogenic Escherichia coli infection - EPEC - Homo sapiens (human) | 4 | 395 | 2 | 2 | 4 | 6 | 549 | 1.00 | 0.01 | 0.01 | 0.9 |
| 384 | 69416 | Activation of Pro-Caspase 8 | 4 | 395 | 0 | 4 | 2 | 6 | 549 | 1.00 | 0.01 | 0.01 | 0.9 |
| 385 | hsa00680 | Methane metabolism - Homo sapiens (human) | 3 | 396 | 1 | 2 | 2 | 4 | 551 | 1.00 | 0.01 | 0.01 | 1.0 |
| 386 | 195399 | VEGF binds to VEGFR leading to receptor dimerization | 3 | 396 | 0 | 3 | 2 | 5 | 550 | 1.00 | 0.01 | 0.01 | 0.8 |
| 387 | 194306 | Neurophilin interactions with VEGF and VEGFR | 3 | 396 | 0 | 3 | 2 | 5 | 550 | 1.00 | 0.01 | 0.01 | 0.8 |
| 388 | 75071 | mRNA Processing | 3 | 396 | 2 | 1 | 3 | 4 | 551 | 1.00 | 0.01 | 0.01 | 1.0 |
| 389 | 75893 | TNF signaling | 3 | 396 | 0 | 3 | 1 | 4 | 551 | 1.00 | 0.01 | 0.01 | 1.0 |
| 390 | 196836 | Vitamin C (ascorbate) metabolism | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 391 | hsa00960 | Alkaloid biosynthesis II - Homo sapiens (human) | 2 | 397 | 0 | 2 | 1 | 3 | 552 | 1.00 | 0.01 | 0.01 | 0.9 |
| 392 | 163210 | Formation of ATP by chemiosmotic coupling | 2 | 397 | 0 | 2 | 1 | 3 | 552 | 1.00 | 0.01 | 0.01 | 0.9 |
| 393 | 111807 | Reduction of nuclear ribonucleoside 5'-diphosphates to deoxyribonucleoside 5'-diphosphates by ribonucleotide reductase and thioredoxin | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 394 | hsa00280 | Valine, leucine and isoleucine degradation - Homo sapiens (human) | 2 | 397 | 2 | 0 | 2 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 395 | 72163 | mRNA Splicing - Major Pathway | 2 | 397 | 1 | 1 | 2 | 3 | 552 | 1.00 | 0.01 | 0.01 | 0.9 |
| 396 | hsa00910 | Nitrogen metabolism - Homo sapiens (human) | 2 | 397 | 0 | 2 | 1 | 3 | 552 | 1.00 | 0.01 | 0.01 | 0.9 |
| 397 | 111752 | Reduction of cytosolic ribonucleoside 5'-diphosphates to deoxyribonucleoside 5'-diphosphates by ribonucleotide reductase and thioredoxin | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 398 | 73857 | RNA Polymerase II Transcription | 2 | 397 | 1 | 1 | 3 | 4 | 551 | 1.00 | 0.01 | 0.01 | 0.7 |
| 399 | 187015 | Activation of TRKA receptors | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 400 | 168254 | Influenza Infection | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 401 | hsa00100 | Biosynthesis of steroids - Homo sapiens (human) | 2 | 397 | 2 | 0 | 2 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 402 | 70171 | Glycolysis | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 403 | 112295 | Elongation and Processing of Capped Transcripts | 2 | 397 | 1 | 1 | 3 | 4 | 551 | 1.00 | 0.01 | 0.01 | 0.7 |
| 404 | 157212 | A third proteolytic cleavage releases NICD | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 405 | 74219 | dGTP formation | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 406 | 114696 | Thrombin-activated activation cascade | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 407 | 76043 | Elongation of Intron-Containing Transcripts and co-transcriptional mRNA splicing | 2 | 397 | 1 | 1 | 3 | 4 | 551 | 1.00 | 0.01 | 0.01 | 0.7 |
| 408 | 70268 | Cori Cycle (interconversion of glucose and lactate) | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 409 | hsa00564 | Glycerophospholipid metabolism - Homo sapiens (human) | 2 | 397 | 2 | 0 | 4 | 4 | 551 | 1.00 | 0.01 | 0.01 | 0.7 |
| 410 | 75815 | Ubiquitin-dependent degradation of Cyclin D | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 411 | 72187 | mRNA 3'-end processing | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 412 | 112296 | Post-Elongation Processing of Intron-Containing pre-mRNA | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 413 | 164952 | The role of Nef in HIV-1 replication and disease pathogenesis | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 414 | 69229 | Ubiquitin-dependent degradation of Cyclin D1 | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 415 | 114665 | G-protein cascades | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 416 | 202433 | Generation of second messenger molecules | 2 | 397 | 0 | 2 | 1 | 3 | 552 | 1.00 | 0.01 | 0.01 | 0.9 |
| 417 | hsa00940 | Phenylpropanoid biosynthesis - Homo sapiens (human) | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 418 | 168927 | Viral dsRNA:TLR3:TRIF Complex Activates RIP1 | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 419 | hsa04140 | Regulation of autophagy - Homo sapiens (human) | 2 | 397 | 0 | 2 | 2 | 4 | 551 | 1.00 | 0.01 | 0.01 | 0.7 |
| 420 | 192076 | Steroid metabolism | 2 | 397 | 1 | 1 | 2 | 3 | 552 | 1.00 | 0.01 | 0.01 | 0.9 |
| 421 | 112168 | Processing of Capped pre-mRNA | 2 | 397 | 1 | 1 | 2 | 3 | 552 | 1.00 | 0.01 | 0.01 | 0.9 |
| 422 | 70614 | Aspartate, asparagine, glutamate, and glutamine metabolism | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 423 | 210990 | PECAM1 interactions | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 424 | 198693 | AKT phosphorylates targets in the nucleus | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 425 | 109688 | Cleavage of Growing Transcript in the Termination Region | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 426 | hsa00071 | Fatty acid metabolism - Homo sapiens (human) | 2 | 397 | 2 | 0 | 2 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 427 | 76044 | Post-Elongation Processing of the Transcript | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 428 | 111447 | Activation of BAD and translocation to mitochondria | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 429 | 73856 | RNA Polymerase II Transcription Termination | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 430 | 72202 | Transport of Mature Transcript to Cytoplasm | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 431 | 75158 | TRAIL signaling | 2 | 397 | 0 | 2 | 2 | 4 | 551 | 1.00 | 0.01 | 0.01 | 0.7 |
| 432 | 74230 | dATP formation | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 433 | hsa05217 | Basal cell carcinoma - Homo sapiens (human) | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 434 | 111457 | Release of apoptotic factors from the mitochondria | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 435 | hsa05110 | Cholera - Infection - Homo sapiens (human) | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 436 | 70895 | Branched-chain amino acid catabolism | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 437 | 111804 | Reduction of nuclear ribonucleoside 5'-diphosphates to deoxyribonucleoside 5'-diphosphates (thioredoxin) | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 438 | 72172 | mRNA Splicing | 2 | 397 | 1 | 1 | 2 | 3 | 552 | 1.00 | 0.01 | 0.01 | 0.9 |
| 439 | hsa00640 | Propanoate metabolism - Homo sapiens (human) | 2 | 397 | 2 | 0 | 3 | 3 | 552 | 1.00 | 0.01 | 0.01 | 0.9 |
| 440 | 187024 | NGF-independant TRKA activation | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 441 | hsa04330 | Notch signaling pathway - Homo sapiens (human) | 2 | 397 | 0 | 2 | 2 | 4 | 551 | 1.00 | 0.01 | 0.01 | 0.7 |
| 442 | hsa00760 | Nicotinate and nicotinamide metabolism - Homo sapiens (human) | 2 | 397 | 1 | 1 | 1 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 443 | 167021 | PLC-gamma1 signalling | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 444 | 73648 | Pyrimidine biosynthesis (interconversion) | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 445 | 111751 | Reduction of cytosolic ribonucleoside 5'-diphosphates to deoxyribonucleoside 5'-diphosphates (thioredoxin) | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 446 | 157118 | Signaling by Notch | 2 | 397 | 0 | 2 | 0 | 2 | 553 | 1.00 | 0.01 | 0.00 | 1.4 |
| 447 | 72203 | Processing of Capped Intron-Containing Pre-mRNA | 2 | 397 | 1 | 1 | 2 | 3 | 552 | 1.00 | 0.01 | 0.01 | 0.9 |
| 448 | 109970 | Global Genomic NER (GG-NER) | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 449 | hsa00550 | Peptidoglycan biosynthesis - Homo sapiens (human) | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 450 | 166207 | S6K1-mediated signalling | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 451 | 69610 | p53-Independent DNA Damage Response | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 452 | 194068 | Metabolism of bile acids and bile salts | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 453 | 72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 454 | 140180 | COX reactions | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 455 | 199920 | CREB phosphorylation | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 456 | 202427 | Phosphorylation of CD3 and TCR zeta chains | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 457 | 74744 | SHC activation | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 458 | 114592 | Collagen adhesion via alpha 2 beta 1 glycoprotein | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 459 | 202430 | Translocation of ZAP-70 to Immunological synapse | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 460 | hsa00450 | Selenoamino acid metabolism - Homo sapiens (human) | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 461 | hsa00310 | Lysine degradation - Homo sapiens (human) | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 462 | 190370 | FGFR1b ligand binding and activation | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 463 | 70108 | Glyceraldehyde 3-phosphate, NAD+, and orthophosphate react to form 1,3-bisphosphoglycerate, NADH, and H+ | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 464 | hsa00053 | Ascorbate and aldarate metabolism - Homo sapiens (human) | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 465 | 166208 | mTORC1-mediated signalling | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 466 | 112297 | Post-Elongation Processing of Intronless pre-mRNA | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 467 | 70263 | Gluconeogenesis | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 468 | 75108 | Activation, myristolyation of BID and translocation to mitochondria | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 469 | 72695 | Formation of the ternary complex, and subsequently, the 43S complex | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 470 | 74257 | Xanthine formation | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 471 | 187042 | TRKA activation by NGF | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 472 | 164938 | Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 473 | 114508 | Phospholipase-mediated signalling | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 474 | 167826 | The fatty acid cycling model | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 475 | 177504 | Retrograde neurotrophin signalling | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 476 | 114516 | Disinhibition of SNARE formation | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 477 | 159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 478 | 72165 | mRNA Splicing - Minor Pathway | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 479 | 74713 | IRS activation | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 480 | 140187 | P450 Prostaglandin isomerizations | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 481 | 159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 482 | hsa00624 | 1- and 2-Methylnaphthalene degradation - Homo sapiens (human) | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 483 | 72702 | Ribosomal scanning and start codon recognition | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 484 | 180534 | Vpu mediated degradation of CD4 | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 485 | 165159 | mTOR signalling | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 486 | 167590 | Nef Mediated CD4 Down-regulation | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 487 | 164944 | Nef and signal transduction | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 488 | hsa00471 | D-Glutamine and D-glutamate metabolism - Homo sapiens (human) | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 489 | 166187 | Mitochondrial Uncoupling Proteins | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 490 | 114664 | G alpha 12 cascade | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 491 | 69601 | Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 492 | 70525 | Alanine metabolism | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 493 | 69613 | p53-Independent G1/S DNA damage checkpoint | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 494 | 114711 | vWF interaction with collagen | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 495 | hsa03022 | Basal transcription factors - Homo sapiens (human) | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 496 | 69017 | CDK-mediated phosphorylation and removal of Cdc6 | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 497 | 190371 | FGFR3b ligand binding and activation | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 498 | 72649 | Translation initiation complex formation | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 499 | 114593 | Collagen adhesion via Gp IV | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 500 | hsa04742 | Taste transduction - Homo sapiens (human) | 1 | 398 | 1 | 0 | 2 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 501 | 68827 | CDT1 association with the CDC6:ORC:origin complex | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 502 | 77595 | Processing of Intronless Pre-mRNAs | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 503 | hsa00130 | Ubiquinone biosynthesis - Homo sapiens (human) | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 504 | 139910 | Activation of BMF and translocation to mitochondria | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 505 | 112411 | ERK2 activation | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 506 | 111446 | Activation of BIM and translocation to mitochondria | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 507 | hsa00970 | Aminoacyl-tRNA biosynthesis - Homo sapiens (human) | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 508 | 75877 | Conversion of Fatty Acyl-CoA to Phosphatidic Acid | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 509 | 77387 | Insulin receptor recycling | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 510 | 109703 | PKB-mediated events | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 511 | 74259 | Purine catabolism | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 512 | 70793 | Leucine catabolism | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 513 | 73854 | RNA Polymerase I Promoter Clearance | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 514 | 73937 | Transcription-coupled NER (TC-NER) | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 515 | 191273 | Cholesterol biosynthesis | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 516 | 165720 | S6K1 signalling | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 517 | 75109 | Triacylglyceride Biosynthesis | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 518 | 75892 | Platelet Adhesion to exposed collagen | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 519 | 159418 | Recycling of bile acids and salts | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 520 | 190377 | FGFR2b ligand binding and activation | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 521 | 73885 | Nucleotide Excision Repair | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 522 | 114666 | G alpha Q cascade | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 523 | 212718 | EGFR interacts with phospholipase C-gamma | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 524 | 75067 | Processing of Capped Intronless Pre-mRNA | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 525 | 191345 | Transformation of lanosterol to cholesterol | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 526 | 139943 | PLC-mediated hydrolysis | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 527 | hsa00232 | Caffeine metabolism - Homo sapiens (human) | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 528 | 167827 | The proton buffering model | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 529 | 111453 | BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 530 | 198745 | Signalling to STAT3 | 1 | 398 | 0 | 1 | 1 | 2 | 553 | 1.00 | 0.00 | 0.00 | 0.7 |
| 531 | 69298 | Association of licensing factors with the pre-replicative complex | 1 | 398 | 0 | 1 | 0 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |
| 532 | 73864 | RNA Polymerase I Transcription | 1 | 398 | 1 | 0 | 1 | 1 | 554 | 1.00 | 0.00 | 0.00 | 1.4 |